Clinical Trial Update: FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer [NA]

View source ↗

Summary

This clinical trial examines using FAPI and FDG PET/MRI imaging to diagnose bladder cancer and predict response to therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• FAPI (Fibroblast activation protein inhibitor)
• FDG (fluorodeoxyglucose)

Snippet

Sponsor: First Affiliated Hospital of Fujian Medical University | Conditions: Urinary Bladder Neoplasms | NA | Status: ACTIVE_NOT_RECRUITING